Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
In the third quarter of 2020, China’s healthcare sector managed to recover from the challenging months of the COVID-19 outbreak in the first half of the year. Nevertheless, COVID-19 continued to affect the ...
View more details
In the second quarter 2020, China’s healthcare sector continued be challenged by the COVID-19 pandemic. As the coronavirus has been affecting the socio-economic reality in the country, in July 2020 China’s State Council released ...
View more details
Healthcare remains in inadequate supply throughout most of the SEA region. The shortage is especially evident in healthcare human resources; for instance, apart from Malaysia and China, all the countries in the SEA region have fewer than 1 physician ...
View more details
In early 2020, a worldwide outbreak of coronavirus occurred, affecting the global socio-economic reality. COVID-19 posed a particular challenge to the healthcare industry. Since the pandemic started in Wuhan, Hubei province, China took a leading role ...
View more details
The growth of China’s healthcare sector continued in the last quarter of 2019, largely stimulated by the online healthcare segment expansion. The growth was attributed to increasing demand for quality healthcare, driven by the country’s ...
View more details
In Q3 2019 China’s healthcare sector continued to expand, stimulated by further structural reforms. The period saw increased government spending on healthcare, with expenditure on health and family planning growing by 12.1% y/y to RMB 369.3bn. ...
View more details
China’s healthcare sector kept growing over the second quarter of 2019. The period was characterised by increased government spending on healthcare, with the amount dedicated to health and family planning rising by 5.9% y/y to RMB 534.5bn in Q2 ...
View more details
The first quarter of 2019 witnessed a continuous growth of China’s healthcare sector. The country promoted the implementation of the Healthy China Initiative, as well as ongoing structural reforms in the sector. The period was characterized by ...
View more details
China’s healthcare sector continued to grow in Q4 2018, largely stimulated by the expansion of online healthcare services. The growth was attributed to increasing demand for quality healthcare, driven by the country’s strong economic ...
View more details
China is the world’s second largest pharmaceutical market after the US and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large share of ageing ...
View more details